Ganjei James Kelly 4
4 · Inmune Bio, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Ganjei James Kelly
Director
Transactions
- Award
Option (right to buy)
2023-02-16+35,000→ 35,000 totalExercise: $9.74Exp: 2033-02-15→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.